Sumant Kulkarni
Stock Analyst at Canaccord Genuity
(0)
# 4705
Out of 5,240 analysts
115
Total ratings
20.29%
Success rate
-20.35%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BioXcel Therapeutics | Maintains: Buy | 7 5 | 0.36 | 1288.89% | 7 | Jan 6, 2025 | |
CervoMed | Maintains: Buy | 65 12 | 2.12 | 466.04% | 4 | Dec 11, 2024 | |
Cybin | Maintains: Buy | 86 86 | 8.78 | 879.5% | 6 | Nov 19, 2024 | |
GH Research | Maintains: Buy | 31 28 | 8.26 | 238.98% | 4 | Nov 18, 2024 | |
ATAI Life Sciences | Maintains: Buy | 11 11 | 1.33 | 727.07% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 23 | 7.71 | 198.31% | 5 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14 14 | 5.04 | 177.78% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 86 83 | 4.84 | 1614.88% | 5 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 16 14 | 6.37 | 119.78% | 1 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 50 48 | 3.37 | 1324.33% | 2 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 107 113 | 126.84 | -10.91% | 4 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 120 12 | 4.71 | 154.78% | 4 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 21 20 | 8.65 | 131.21% | 3 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 154 164 | 139.49 | 17.57% | 13 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 36 26 | 4.66 | 457.94% | 2 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 21 17 | 7.46 | 127.88% | 4 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 40 33 | 16.89 | 95.38% | 13 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 310 305 | 143 | 113.29% | 14 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 10 2 | n/a | n/a | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | n/a | n/a | 1 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 4 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 101 150 | 35.52 | 322.3% | 4 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 20 | n/a | n/a | 4 | Sep 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 110 120 | n/a | n/a | 2 | Feb 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 2 | Jan 31, 2017 |